Vatsala Kaul

Vatsala Kaul has a strong background in drug safety and risk management writing. Vatsala currently works at SIRO Clinpharm Pvt. Ltd. as a Principal DSRM Writer, where they conduct drug coordination activities and authors and reviews various reports for therapeutic areas including oncology, neuroscience, infections, and immunology. Prior to this role, they were a Senior Drug Safety & Risk Management Writer at the same company, focusing on drug coordination activities for the oncology therapeutic area.

Before joining SIRO Clinpharm Pvt. Ltd., Vatsala worked at PAREXEL as a Principal Medical Writer and later as an Associate Team Lead. In these roles, they served the pharmaceutical industries globally and specialized in drug safety pharmacovigilance services. Vatsala had extensive knowledge of drug safety databases and ensured compliance with regulatory timelines for adverse event reporting.

Earlier in their career, Vatsala worked at Quantum Solutions India, where they held various roles in pharmacovigilance, including Senior Pharmacovigilance Specialist, Pharmacovigilance Analyst, and Pharmacovigilance Scientist.

Overall, Vatsala Kaul has a diverse range of experience in drug safety and risk management writing, with expertise in various therapeutic areas and regulatory compliance.

Vatsala Kaul obtained a Master of Science (MSc) degree in Biochemistry from Panjab University, which they completed from 2005 to 2010. Additionally, they have certifications in Regulatory Affairs & Medical Writing from Udemy, obtained in 2022, and certifications in Signal detection and causality assessment, as well as Statistical reasoning and algorithms in pharmacovigilance, both obtained from the Uppsala Monitoring Centre in 2019.